Delivery Order SPE2DR25D3103-SPE2DR26F9X85
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $23,272.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (40 gram/400 ml vial), with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract that will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a single transaction within AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials, with a contract ceiling value of $11,636.00 and an ultimate completion date of June 27, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $58,860.24 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials on December 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of January 12, 2026, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 10 gram/100 mL vials valued at $1,220.94. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,311.23 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials with an ultimate completion date of June 11, 2025. This firm fixed-price delivery order represents a non-set-aside award, reflecting open competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency has awarded a delivery order valued at $10,743.66 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 20 gram/200 mL vials. This firm fixed price delivery order, issued on November 3, 2025, with completion scheduled for November 25, 2025, is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 9, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract is a firm fixed price delivery order with a ceiling value of $224,205.12 and an ultimate completion date of September 30, 2025. This award was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of GAMUNEX-C (20 gram/200 milliliter vials) with a ceiling value of $57,052.32 and an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a supply requirement for an immunoglobulin product commonly used in military and federal healthcare systems. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9X85Delivery Order
The Defense Logistics Agency awarded a $19,015.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of GAMUNEX-C 10 gram/100 milliliter vials. This delivery order, with an ultimate completion date of February 6, 2026, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The current delivery order for GAMUNEX-C, an immunoglobulin product used for immunodeficiency treatment, exemplifies the critical medical supplies that AmerisourceBergen regularly furnishes to military treatment facilities and federal healthcare systems through this contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 1/14/26 |